155 related articles for article (PubMed ID: 27599781)
1. Importance of the interaction between immune cells and tumor vasculature mediated by thalidomide in cancer treatment (Review).
Wang X; Shen Y; Li S; Lv M; Zhang X; Yang J; Wang F; Yang J
Int J Mol Med; 2016 Oct; 38(4):1021-9. PubMed ID: 27599781
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide in the treatment of cancer.
Adlard JW
Anticancer Drugs; 2000 Nov; 11(10):787-91. PubMed ID: 11142686
[TBL] [Abstract][Full Text] [Related]
3. [Using thalidomide against pathological neovascularization].
Eisenkraft A; Luria S; Robenshtok E; Hourvitz A
Harefuah; 2003 Mar; 142(3):212-6, 237. PubMed ID: 12696477
[TBL] [Abstract][Full Text] [Related]
4. Current status of thalidomide in the treatment of cancer.
Rajkumar SV
Oncology (Williston Park); 2001 Jul; 15(7):867-74; discussion 877-9. PubMed ID: 11499688
[TBL] [Abstract][Full Text] [Related]
5. [Importance of thalidomide in the treatment of cancer].
Bay JO; Tournilhac O
Bull Cancer; 2000 Apr; 87(4):301-2. PubMed ID: 10858046
[No Abstract] [Full Text] [Related]
6. Tumor Vasculatures: A New Target for Cancer Immunotherapy.
Liu Z; Wang Y; Huang Y; Kim BYS; Shan H; Wu D; Jiang W
Trends Pharmacol Sci; 2019 Sep; 40(9):613-623. PubMed ID: 31331639
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide, an antiangiogenic agent with clinical activity in cancer.
Ng SS; Brown M; Figg WD
Biomed Pharmacother; 2002 Jun; 56(4):194-9. PubMed ID: 12109812
[TBL] [Abstract][Full Text] [Related]
8. Novel biologically based therapies for myeloma.
Anderson KC
Cancer J; 2001; 7 Suppl 1():S19-23. PubMed ID: 11504280
[TBL] [Abstract][Full Text] [Related]
9. A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma.
Rajkumar SV; Witzig TE
Cancer Treat Rev; 2000 Oct; 26(5):351-62. PubMed ID: 11006136
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide-a notorious sedative to a wonder anticancer drug.
Zhou S; Wang F; Hsieh TC; Wu JM; Wu E
Curr Med Chem; 2013; 20(33):4102-8. PubMed ID: 23931282
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory analogs of thalidomide inhibit growth of Hs Sultan cells and angiogenesis in vivo.
Lentzsch S; LeBlanc R; Podar K; Davies F; Lin B; Hideshima T; Catley L; Stirling DI; Anderson KC
Leukemia; 2003 Jan; 17(1):41-4. PubMed ID: 12529658
[TBL] [Abstract][Full Text] [Related]
12. Revisiting thalidomide: fighting with caution against idiopathic pulmonary fibrosis.
Horton MR; Hallowell RW
Drugs Today (Barc); 2012 Oct; 48(10):661-71. PubMed ID: 23110262
[TBL] [Abstract][Full Text] [Related]
13. [New observations support the significance of angiogenesis in myeloma].
Lundberg LG; Lerner R; Palmblad J
Lakartidningen; 2001 Nov; 98(45):4985-90. PubMed ID: 11816901
[TBL] [Abstract][Full Text] [Related]
14. Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.
Du W; Hattori Y; Hashiguchi A; Kondoh K; Hozumi N; Ikeda Y; Sakamoto M; Hata J; Yamada T
Pathol Int; 2004 May; 54(5):285-94. PubMed ID: 15086832
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide-analogue biology: immunological, molecular and epigenetic targets in cancer therapy.
Shortt J; Hsu AK; Johnstone RW
Oncogene; 2013 Sep; 32(36):4191-202. PubMed ID: 23318436
[TBL] [Abstract][Full Text] [Related]
16. Failure of thalidomide to inhibit tumor growth and angiogenesis in vivo.
Gutman M; Szold A; Ravid A; Lazauskas T; Merimsky O; Klausner JM
Anticancer Res; 1996; 16(6B):3673-7. PubMed ID: 9042240
[TBL] [Abstract][Full Text] [Related]
17. License for destruction: tumor-specific cytokine targeting.
Johansson A; Hamzah J; Ganss R
Trends Mol Med; 2014 Jan; 20(1):16-24. PubMed ID: 24169116
[TBL] [Abstract][Full Text] [Related]
18. The potential of immunomodulatory drugs in the treatment of solid tumors.
Dalgleish A; Galustian C
Future Oncol; 2010 Sep; 6(9):1479-84. PubMed ID: 20919830
[TBL] [Abstract][Full Text] [Related]
19. [Role of thalidomide in the treatment of multiple myeloma].
Mikala G; Jákó J; Vályi-Nagy I
Orv Hetil; 2001 Aug; 142(33):1789-98. PubMed ID: 11573449
[TBL] [Abstract][Full Text] [Related]
20. The thalidomide saga.
Melchert M; List A
Int J Biochem Cell Biol; 2007; 39(7-8):1489-99. PubMed ID: 17369076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
